Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1990 Jan 15;265(2):471-7.
doi: 10.1042/bj2650471.

Isolation and characterization of a membrane-attack-complex-inhibiting protein present in human serum and other biological fluids

M J Watts  1 , J R Dankert, E P Morgan
Affiliations

Isolation and characterization of a membrane-attack-complex-inhibiting protein present in human serum and other biological fluids

M J Watts et al. Biochem J. .

Abstract

We have previously reported the isolation of a membrane-attack-complex-inhibiting protein (MIP) from human erythrocyte membranes [Watts, Patel & Morgan (1987) Complement 4, 236] and the production of polyclonal antibodies to this protein. Here we report the identification in plasma, urine, saliva and cerebrospinal fluid of a protein immunochemically identical with the membrane-derived MIP. The protein has been isolated from plasma by immunoaffinity chromatography on an anti-(erythrocyte MIP)-Sepharose column and shown by SDS/polyacrylamide-gel electrophoresis to be of similar molecular mass to the erythrocyte protein (55 kDa non-reduced and 65 kDa under reducing conditions). Monoclonal antibodies have been raised against plasma MIP and used to establish a two-site enzyme-linked immunoadsorbent assay, enabling quantification of MIP in plasma, urine and cerebrospinal fluid. Plasma MIP, though not able to incorporate spontaneously into membranes, was deposited on heterologous and homologous erythrocyte membranes during complement activation in a C8-dependent manner. Depletion of MIP from plasma resulted in enhancement of the lytic capacity of the plasma on heterologous erythrocytes.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. J Immunol. 1979 Sep;123(3):1245-52 - PubMed
    1. J Immunol. 1977 Oct;119(4):1482-5 - PubMed
    1. Methods Enzymol. 1981;73(Pt B):3-46 - PubMed
    1. Proc Natl Acad Sci U S A. 1981 Aug;78(8):5118-21 - PubMed
    1. J Immunol. 1983 Jun;130(6):2809-13 - PubMed

Publication types